PubMed

Metabolic syndrome and type 2 diabetes mellitus: focus on peroxisome proliferator activated receptors (PPAR).

Tenenbaum A, Fisman EZ, Motro M.

Cardiovasc Diabetol. 2003 Mar 23;2:4.PMID: 12834541 [PubMed]Related articlesFree article

Macrovascular complications of metabolic syndrome: an early intervention is imperative.

Tenenbaum A, Motro M, Schwammenthal E, Fisman EZ.

Int J Cardiol. 2004 Nov;97(2):167-72. Review.PMID: 15458679 [PubMed - indexed for MEDLINE]Related articles

Peroxisome proliferator-activated receptor (PPAR) in metabolic syndrome and type 2 diabetes mellitus.

Jay MA, Ren J.

Curr Diabetes Rev. 2007 Feb;3(1):33-9. Review.PMID: 18220654 [PubMed - indexed for MEDLINE]Related articles

New approach in the treatment of T2DM and metabolic syndrome (focus on a novel insulin sensitizer).

Tjokroprawiro A.

Acta Med Indones. 2006 Jul-Sep;38(3):160-6. Review.PMID: 17119268 [PubMed - indexed for MEDLINE]Related articlesFree article

Peroxisome proliferator-activated receptor family and its relationship to renal complications of the metabolic syndrome.

Guan Y.

J Am Soc Nephrol. 2004 Nov;15(11):2801-15. Review.PMID: 15504933 [PubMed - indexed for MEDLINE]Related articlesFree article

[PPAR family and its relationship to metabolic syndrome]

Zhang XY, Chen LH, Guan YF.

Sheng Li Ke Xue Jin Zhan. 2005 Jan;36(1):6-12. Review. Chinese. PMID: 15881336 [PubMed - indexed for MEDLINE]Related articles

Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons.

Tenenbaum A, Motro M, Fisman EZ.

Cardiovasc Diabetol. 2005 Sep 16;4:14. Review.PMID: 16168052 [PubMed - indexed for MEDLINE]Related articlesFree article

Inflammation in diabetes mellitus: role of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma agonists.

Libby P, Plutzky J.

Am J Cardiol. 2007 Feb 19;99(4A):27B-40B. Epub 2006 Dec 22. Review.PMID: 17307056 [PubMed - indexed for MEDLINE]Related articles

Fine tuning of PPAR ligands for type 2 diabetes and metabolic syndrome.

Ramachandran U, Kumar R, Mittal A.

Mini Rev Med Chem. 2006 May;6(5):563-73. Review.PMID: 16719831 [PubMed - indexed for MEDLINE]Related articles

Treating the metabolic syndrome using angiotensin receptor antagonists that selectively modulate peroxisome proliferator-activated receptor-gamma.

Pershadsingh HA.

Int J Biochem Cell Biol. 2006;38(5-6):766-81. Epub 2005 Sep 9. Review.PMID: 16298156 [PubMed - indexed for MEDLINE]Related articles

Management issues in the metabolic syndrome.

Deedwania PC, Gupta R.

J Assoc Physicians India. 2006 Oct;54:797-810. Review.PMID: 17214277 [PubMed - indexed for MEDLINE]Related articles

Novel approach to treat insulin resistance, type 2 diabetes, and the metabolic syndrome: simultaneous activation of PPARalpha, PPARgamma, and PPARdelta.

Evans JL, Lin JJ, Goldfine ID.

Curr Diabetes Rev. 2005 Aug;1(3):299-307. Review.PMID: 18220606 [PubMed - indexed for MEDLINE]Related articles

Dual Peroxisome Proliferator-Activated Receptor-alpha/gamma Agonists : In the Treatment of Type 2 Diabetes Mellitus and the Metabolic Syndrome.

Pershadsingh HA.

Treat Endocrinol. 2006;5(2):89-99.PMID: 16542049 [PubMed - in process]Related articles

PPARs as targets for the modulation of cardiovascular risk factors associated with the metabolic syndrome.

Fernandez AZ.

Curr Opin Investig Drugs. 2004 Sep;5(9):936-40. Review.PMID: 15503647 [PubMed - indexed for MEDLINE]Related articles

Oral antidiabetic agents: current role in type 2 diabetes mellitus.

Krentz AJ, Bailey CJ.

Drugs. 2005;65(3):385-411. Review.PMID: 15669880 [PubMed - indexed for MEDLINE]Related articles

Cardiovascular metabolic syndrome - an interplay of, obesity, inflammation, diabetes and coronary heart disease.

Rana JS, Nieuwdorp M, Jukema JW, Kastelein JJ.

Diabetes Obes Metab. 2007 May;9(3):218-32. Review.PMID: 17391148 [PubMed - indexed for MEDLINE]Related articles

Inhibition of postprandial hyperglycemia by acarbose is a promising therapeutic strategy for the treatment of patients with the metabolic syndrome.

Yamagishi S, Nakamura K, Takeuchi M.

Med Hypotheses. 2005;65(1):152-4. Epub 2005 Jan 28.PMID: 15893133 [PubMed - indexed for MEDLINE]Related articles

Challenges associated with metabolic syndrome.

Spinler SA.

Pharmacotherapy. 2006 Dec;26(12 Pt 2):209S-217S. Review.PMID: 17125447 [PubMed - indexed for MEDLINE]Related articles

Metabolic syndrome-interdependence of the cardiovascular and metabolic pathways.

Caglayan E, Blaschke F, Takata Y, Hsueh WA.

Curr Opin Pharmacol. 2005 Apr;5(2):135-42. Review.PMID: 15780821 [PubMed - indexed for MEDLINE]Related articles

Evolution of peroxisome proliferator-activated receptor agonists.

Chang F, Jaber LA, Berlie HD, O'Connell MB.

Ann Pharmacother. 2007 Jun;41(6):973-83. Epub 2007 May 22. Review.PMID: 17519293 [PubMed - indexed for MEDLINE]Related articles